Caxton Corp Portfolio Holdings
Caxton Corp
- $23.3 Million
- Q3 2024
Caxton Corp has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $23.3 Million distributed in 12 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Xeris Biopharma Holdings, Inc. with a value of $14.6M, Rezolute, Inc. with a value of $6.4M, Spdr S&P 500 ETF Trust with a value of $1.65M, Berkshire Hathaway Inc Class B with a value of $529K, and Compass Therapeutics, Inc. with a value of $79K.
Examining the 13F form we can see an increase of $4.57M in the current position value, from $18.7M to 23.3M.
Caxton Corp is based out at Princeton, NJ
Below you can find more details about Caxton Corp portfolio as well as his latest detailed transactions.